Evidence Hub

Responsiveness to metformin in girls with androgen excess: collective influence of genetic polymorphisms

Díaz M, López-Bermejo A, Sánchez-Infantes D, Bassols J, de Zegher F, Ibáñez L

Fertility and sterility, 2011

Abstract

OBJECTIVE: To study the relationship between the responsiveness to metformin in girls with androgen excess and combinations of genetic variants-as reflected in a polymorphism score-in single nucleotide polymorphisms (OCT1, STK11, and FTO genes) and in the repeat numbers within the AR and SHBG genes.

DESIGN: Longitudinal (1-year) follow-up.

SETTING: University hospital.

PATIENT(S): Hyperandrogenic adolescent girls receiving metformin.

INTERVENTION(S): Single nucleotide polymorphisms and repeat numbers were assessed in 104 adolescent girls with androgen excess. The polymorphism score was the sum of subscores given for response alleles in OCT1, STK11, and FTO and for high repeat numbers in SHBG and AR alleles.

MAIN OUTCOME MEASURE(S): The response to metformin (850 mg/d) was judged by changes over 1 year in endocrine-metabolic state and body composition.

RESULT(S): Changes in fasting insulin levels, triacylglycerol levels, LDL-HDL ratio, and body composition differed strikingly by polymorphism score.

CONCLUSION(S): Collectively, genetic polymorphisms had a major influence on the responsiveness to metformin in adolescent girls with androgen excess.

How strong is the evidence?

Evidence Hub reads this as a clinical trial, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free